Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medgenics Inc (NYSE MKT LLC:MDGN)

7.69
Delayed Data
As of Sep 01
 -0.22 / -2.78%
Today’s Change
3.68
Today|||52-Week Range
9.63
+51.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization98.0K145.0K177.0K225.0K
 
 
 
 
 
 
Operating ExpensesGross Income-98.0K---177.0K-225.0K
 
 
 
 
General Expenses9.9M14.2M17.5M18.7M
 
 
 
 
 
Research And Development5.1M7.2M7.3M8.3M
 
 
 
 
 
Total Operating Expenses10.0M14.4M17.6M18.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.0M-14.4M-17.6M-18.9M
 
 
 
 
 
Extraordinary Credit2.1M0.00720.0K585.0K
 
 
 
 
Extraordinary Charge-125.0K-2.3M-186.0K--
 
 
 
 
Interest Expense On Debt71.0K0.000.0020.0K
 
 
 
Other Expenses10.0K-93.0K-17.0K-48.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.1M-16.8M-17.1M-18.4M
 
 
 
 
 
Income Taxes-3.0K-1.7M-17.0K-12.0K
 
 
 
 
 
Net Income-8.1M-15.1M-17.1M-18.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.4M11.0M17.6M19.2M
 
 
 
 
 
Shares To Calculate EPS Diluted8.4M11.0M17.7M19.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.96-$1.37-$1.06-$1.00
 
 
 
 
 
EPS Diluted-$0.96-$1.37-$1.06-$1.00